A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)

Clinical trial NCT01513239 · COMPLETED

Trial details

NCT number: NCT01513239
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Clostridium Difficile Infection

Start date: 2012-02-01
Primary completion: 2015-05-22
Enrollment: 1203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.